Abstract
AbstractMultidrug-resistant tuberculosis (MDR-TB) is a major threat to the eradication of tuberculosis. TB control strategies need to be adapted to the necessities of different countries and adjusted in high-risk areas. In this study, we analysed the spatial distribution of the MDR- and non-MDR-TB cases across municipalities in Continental Portugal between 2000 and 2016. We used Bayesian spatial models to estimate age-standardized notification rates and standardized notification ratios in each area, and to delimitate high- and low-risk areas, those whose standardized notification ratio is significantly above or below the country’s average, respectively. The spatial distribution of MDR- and non-MDR-TB was not homogeneous across the country. Age-standardized notification rates of MDR-TB ranged from 0.08 to 1.20 and of non-MDR-TB ranged from 7.73 to 83.03 notifications per 100,000 population across the municipalities. We identified 36 high-risk areas for non-MDR-TB and 8 high-risk areas for MDR-TB, which were simultaneously high-risk areas for non-MDR-TB. We found a moderate correlation (ρ = 0.653; 95% CI 0.457–0.728) between MDR- and non-MDR-TB standardized notification ratios. We found heterogeneity in the spatial distribution of MDR-TB across municipalities and we identified priority areas for intervention against TB. We recommend including geographical criteria in the application of molecular drug resistance to provide early MDR-TB diagnosis, in high-risk areas.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. WHO Regional Office for Europe/European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2019–2017 data. (WHO Regional Office for Europe, Copenhagen, 2019).
2. Gunther, G., Gomez, G. B., Lange, C., Rupert, S. & van Leth, F. Availability, price and affordability of anti-tuberculosis drugs in Europe: A TBNET survey. Eur. Respir. J. 45, 1081–1088. https://doi.org/10.1183/09031936.00124614 (2015).
3. Lonnroth, K. et al. Towards tuberculosis elimination: An action framework for low-incidence countries. Eur. Respir. J. 45, 928–952. https://doi.org/10.1183/09031936.00214014 (2015).
4. WHO. Anti-tuberculosis drug resistance in the world. WHO/TB/97.229. (Geneva, Switzerland, 1997).
5. Kendall, E. A., Fofana, M. O. & Dowdy, D. W. Burden of transmitted multidrug resistance in epidemics of tuberculosis: A transmission modelling analysis. Lancet Respir. Med. 3, 963–972. https://doi.org/10.1016/s2213-2600(15)00458-0 (2015).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献